Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: Demonstration by fluorescence in situ hybridization

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 7, 1997, Pages 701-706

  Lones, Mark A ^a   Lopez Terrada, Dolores ^b   Weiss, Lawrence M ^c   Shintaku, I Peter ^e   Said, Jonathan W ^d  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER TUMOR; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN DONOR; REOPERATION; X CHROMOSOME; Y CHROMOSOME;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER; LIVER DISEASES; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; SEX CHROMOSOMES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030738881     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981;41: 4262-4279.
2. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression, Am J Pathol, 1988;133:173-192.
3. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood,.1995;85:552-565.
4. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol. 1995;103:748-755.
5. Spiro I, Yandell DW, Li C, et al. Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med, 1993;329:27-29. Brief Report.
6. Armes JE, Angus P, Sotlhey MC, et al. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer. 1994;74: 2436-2441.
7. Chadburn A, Cesarman E, Michler RE, Knowles DM. Post-transplantation lymphoproliferative disorders (PT-LPDs) arising in solid organ transplant recipients are of recipient origin. Am J Pathol. 1995;147:1862-1870.
8. Said JW, Pinkus GS, Lones MA, Preston MA, Shintaku IP. Expression of bcl-2 oncogene protein in malignant lymphomas, including Hodgkin's disease and non-Hodgkin's lymphomas of T-cell phenotype. Appl Immunohistochem. 1993;1: 108-114.
9. Walts AE, Shintaku IP, Said JW. Diagnosis of malignant lymphoma in effusions from AIDS patients by gene rearrangement. Am J Clin Pathol. 1990;94:170-175.
10. Alshak N, Jiminez AM, Gedebou M, et al. Epstein-Barr virus infection in liver transplantation patients: correlation of histopathology and semiquantitative Epstein-Barr virus-DNA recovery using polymerase chain reaction. Hum Pathol. 1993;24:1306-1312.
11. Chang KL, Chen YY, Shibata D, Weiss LM. Decription of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
12. Randhawa PS, Jaffe R, Dematris AJ, et al. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med. 1992;327:1710-1714.
13. Pinkus GS, Lones MA, Shintaku IP, Said JW. Immunohistochemical detection of Epstein-Barr virus encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease, Mod Pathol. 1994;7:454-461.
14. Dewald GW, Schad CR, Christensen ER, et al. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant. 1993;12:149-154.
15. Lawler SD, Baker MC, Harris H, Morgenstern GR. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin. Br J Haematol. 1984;56:431-443.
16. Choo KHA. In situ hybridization protocols. In: Choo KHA, ed. Methods in Molecular Biology. Vol. 33. Totowa, NJ: Humana Press; 1994.
17. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985;43: 831-840.
18. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988;72:520-529.
19. Schubach WH, Hackman R, Nieman PE, Miller G, Thomas ED. A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia. Blood. 1982;60:180-187.
20. Hjelle B, Evans-Holm M, Yen TSB, Garovoy M, Guis M, Edman JC. A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation. 1909;47:945-948.
21. Gassel AM, Westphal E, Hansnnann ML, Leimenstoll G, Gassel HJ. Malignant lymphoma of donor origin after renal transplantation: a case report. Hum Pathol. 1991;22:1291-1293.
22. Hegele RG, Bicknell SG, Bailey DJ, Cameron RG. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft. Arch Pathol Lab Med. 1994;118: 795-796.
23. Alfieri C, Tanner J, Carpentier L, et al. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipients blood and orapharynx. Blood. 1996;87:812-817.